Impact of prior gestational age at preterm delivery on effectiveness of 17-alpha-hydroxyprogesterone caproate in practice

American Journal of Obstetrics and Gynecology

Volumn 203, Issue 3, 2010, Pages

  Gonzlez Quintero, Victor H ^a   De La Torre, Lesley ^a   Rhea, Debbie J ^b   Tudela, Carmen M ^a   Vazquez Vera, Enrique ^a   Desch, Cheryl ^b   Istwan, Niki B ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Alere Women's and Children's Health ^*  (United States)

Author keywords

17 alpha hydroxyprogesterone caproate; gestational age at delivery; spontaneous preterm birth

Indexed keywords

HYDROXYPROGESTERONE CAPROATE;

ADULT; ARTICLE; DELIVERY; DRUG EFFICACY; FEMALE; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; OUTPATIENT CARE; PREGNANCY; PREGNANT WOMAN; PREMATURE LABOR; PRIORITY JOURNAL; PROPHYLAXIS;

17-ALPHA-HYDROXYPROGESTERONE; ADULT; FEMALE; GESTATIONAL AGE; HUMANS; PREGNANCY; PREGNANCY, HIGH-RISK; PREMATURE BIRTH; RECURRENCE; RETROSPECTIVE STUDIES;

EID: 77956343265     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2010.06.020     Document Type: Article

References (8)

1. J.A. Martin, B.E. Hamilton, and P.D. Sutton Births: final data for 2006 Natl Vital Stat Rep 57 2009 1 104
2. B.M. Mercer, R.L. Goldenberg, and A.H. Moawad The preterm prediction study: effect of gestational age and cause of preterm birth on subsequent obstetric outcome Am J Obstet Gynecol 181 1999 1216 1221
3. P.J. Meis, M. Klebanoff, and E. Thom Prevention of recurrent preterm delivery by 17-alpha-hydroxyprogesterone caproate N Engl J Med 348 2003 2379 2385
4. C.Y. Spong, P.J. Meis, and E.A. Thom Progesterone for prevention of recurrent preterm birth: impact of gestational age at previous delivery Am J Obstet Gynecol 193 2005 1127 1131
5. V.H. Gonzlez-Quintero, N.B. Istwan, D.J. Rhea, L. Smarkusky, M.C. Hoffman, and G.J. Stanziano Gestational age at initiation of 17α-hydroxyprogesterone caproate (17P) and recurrent preterm delivery J Matern Fetal Neonatal Med 20 2007 249 252
6. H.Y. How, J.R. Barton, N.B. Istwan, D.J. Rhea, and G.J. Stanziano Prophylaxis with 17-alpha-hydroxyprogesterone caproate for prevention of recurrent preterm delivery: does gestational age at initiation of treatment matter? Am J Obstet Gynecol 197 2007 260.e1 260.e4
7. A. Rebarber, L.A. Ferrara, and M.L. Hanley Increased recurrence of preterm delivery with early cessation of 17-alpha-hydroxyprogesterone caproate Am J Obstet Gynecol 196 2007 224.e1 224.e4
8. C. Rittenberg, R.B. Newman, N.B. Istwan, D.J. Rhea, and G.J. Stanziano Preterm birth prevention by 17 alpha-hydroxyprogesterone caproate vs daily nursing surveillance J Reprod Med 54 2009 47 52